GSRTX | NABIX | GSRTX / NABIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 13 years | - |
Gain YTD | 2.037 | 1.163 | 175% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.72B | 89.6M | 5,268% |
Annual Yield % from dividends | 2.59 | 0.92 | 283% |
Returns for 1 year | 9.11 | 6.19 | 147% |
Returns for 3 years | 14.60 | 16.55 | 88% |
Returns for 5 years | 11.45 | 21.54 | 53% |
Returns for 10 years | 21.62 | 26.89 | 80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EIFGX | 29.54 | 0.52 | +1.79% |
Eaton Vance Focused Growth Opps I | |||
JAGLX | 68.82 | 0.02 | +0.03% |
Janus Henderson Global Life Sciences T | |||
CNPSX | 62.91 | N/A | N/A |
Consumer Staples UltraSector ProFund Svc | |||
VWYIX | 45.01 | N/A | N/A |
Voya Small Cap Growth R | |||
WOOQX | 19.02 | -0.10 | -0.52% |
JPMorgan SMID Cap Equity R4 |